Page 43 - Compass Pathways News Today

By Arno Schuetze and Nadine Schimroszik BERLIN (Reuters) - German investor Christian Angermayer is planning to list a blank-cheque company in New York, embracing a trend that has seen a swathe of entrepreneurs tapping into investor interest in new offerings pa, two people close to the matter said. His Frontier Acquisition Corp., a special purpose acquisition company (SPAC), is planning to sell shares worth $200 million and will have a biotech focus, the sources said, adding that an official...

/PRNewswire/ -- Psychedelics have made some spectacular breakthroughs to gain legitimacy as mental healthcare products and to become an emerging health and...

To revist this article, visit My Profile, then View saved stories. Psilocybin—the active compound in magic mushrooms—is one of a handful of psychedelic drugs that have shown real clinical promise in the treatment of anxiety, depression, and addiction.Jeanette Mundt, My Lee Reynold’s Mushrooms, 2016, oil on canvas, 24 x 18 in. Courtesy of the artist and The Green Gallery, Milwaukee. To listen to Maya Singer read this profile, click the play button below: AT SEVEN O’ CLOCK on a recent ...

The capital markets have seen a snowballing effect as innovations in mental health therapy materialize through psychedelic research and medicine. The mental health crisis is nothing new. The World Health Organization (WHO) estimates that, globally, over 700 million people are affected by mental health disorders. The global pandemic is likely to increase those numbers as the shift to remote work further exposes how widespread the mental health epidemic really is. But there is positive news on th...

Psilocybin Could be a Major Game Changer for Millions of People The psychedelics story is quickly gaining momentum. Over the last few months, Denver, Oakland, and Santa Cruz have recently legalized its use. Joining them, Ann Arbor, Michigan lawmakers voted to decriminalize psilocybin mushrooms, as well. Now, even Florida could soon legalize magic mushrooms by 2022. In fact, according to Miami New Times, “A recent bill introduced by Florida House Rep. Michael Grieco aims to legaliz...

The Nascent Psychedelic Industry is Booming as Several Companies Have Gone Public and More are Expected to Follow This Route in 2021 to Attract More Capital From Institutional and Retail Investors Competition among the dozens of biopharmaceutical companies is fierce. Many are seeking more capital to conduct expensive and lengthy drug trials and develop intellectual property to synthesize the molecules to help treat various mental disorders. The companies that can bring their Psychedelic drugs...

Compass Pathways Files for an IPO at NASDAQ UK-based Compass Pathways wants to become the first psychedelics company to list on a major U.S. stock exchange. The psilocybin research company intends to make its initial public offering (IPO) through NASDAQ under the ticker symbol... Read More... Dont Miss Any Updates! News Directly in Your Inbox Subscribe to:

Horizons ETFs will begin offering investors exposure to the rising psychedelics market with the launch of a brand-new fund. Psychedelics investing is reaching its next milestone as the first exchange-traded fund (ETF) entirely dedicated to the growing space gets ready to debut. The Horizons Psychedelic Stock Index ETF will begin trading on Wednesday (January 27) under the ticker symbol PSYK. The fund will offer exposure to a basket of psychedelics companies listed in North America. PSYK was off...

/PRNewswire/ -- PitchBook, the premier data provider for the private and public equity markets, today released its 2020 Annual European Venture Report, which...

Atai Life Sciences t announced on Tuesday a new research collaboration with Massachusetts General Hospital, the largest teaching hospital of Harvard Medical School. The partnership will help advance the hospital’s Center for Neuroscience of Psychedelics, a recently-launched center focused on studying the mechanisms behind the therapeutic effects of psychedelics, with the aims of developing novel mental health treatments. “This collaboration may lead to the discovery of novel mechanisms of ...